Copyright Reports & Markets. All rights reserved.

Global Human Fibrinogen Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Human Fibrinogen Market Overview

      • 1.1 Product Overview and Scope of Human Fibrinogen
      • 1.2 Human Fibrinogen Segment by Type
        • 1.2.1 Global Human Fibrinogen Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Pure Human Fibrinogen
        • 1.2.3 Fibrinogen Concentrate (Human)
      • 1.3 Human Fibrinogen Segment by Application
        • 1.3.1 Human Fibrinogen Consumption Comparison by Application (2014-2025)
        • 1.3.2 Congenital Fibrinogen Deficiency
        • 1.3.3 Surgical Procedures
      • 1.3 Global Human Fibrinogen Market by Region
        • 1.3.1 Global Human Fibrinogen Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Human Fibrinogen Market Size
        • 1.4.1 Global Human Fibrinogen Revenue (2014-2025)
        • 1.4.2 Global Human Fibrinogen Production (2014-2025)

      2 Global Human Fibrinogen Market Competition by Manufacturers

      • 2.1 Global Human Fibrinogen Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Human Fibrinogen Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Human Fibrinogen Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Human Fibrinogen Production Sites, Area Served, Product Types
      • 2.5 Human Fibrinogen Market Competitive Situation and Trends
        • 2.5.1 Human Fibrinogen Market Concentration Rate
        • 2.5.2 Human Fibrinogen Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Human Fibrinogen Production Market Share by Regions

      • 3.1 Global Human Fibrinogen Production Market Share by Regions
      • 3.2 Global Human Fibrinogen Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Human Fibrinogen Production
        • 3.4.1 North America Human Fibrinogen Production Growth Rate (2014-2019)
        • 3.4.2 North America Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Human Fibrinogen Production
        • 3.5.1 Europe Human Fibrinogen Production Growth Rate (2014-2019)
        • 3.5.2 Europe Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Human Fibrinogen Production (2014-2019)
        • 3.6.1 China Human Fibrinogen Production Growth Rate (2014-2019)
        • 3.6.2 China Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Human Fibrinogen Production (2014-2019)
        • 3.7.1 Japan Human Fibrinogen Production Growth Rate (2014-2019)
        • 3.7.2 Japan Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Human Fibrinogen Consumption by Regions

      • 4.1 Global Human Fibrinogen Consumption by Regions
      • 4.2 North America Human Fibrinogen Consumption (2014-2019)
      • 4.3 Europe Human Fibrinogen Consumption (2014-2019)
      • 4.4 China Human Fibrinogen Consumption (2014-2019)
      • 4.5 Japan Human Fibrinogen Consumption (2014-2019)

      5 Global Human Fibrinogen Production, Revenue, Price Trend by Type

      • 5.1 Global Human Fibrinogen Production Market Share by Type (2014-2019)
      • 5.2 Global Human Fibrinogen Revenue Market Share by Type (2014-2019)
      • 5.3 Global Human Fibrinogen Price by Type (2014-2019)
      • 5.4 Global Human Fibrinogen Production Growth by Type (2014-2019)

      6 Global Human Fibrinogen Market Analysis by Applications

      • 6.1 Global Human Fibrinogen Consumption Market Share by Application (2014-2019)
      • 6.2 Global Human Fibrinogen Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Human Fibrinogen Business

      • 7.1 CSL Behring
        • 7.1.1 CSL Behring Human Fibrinogen Production Sites and Area Served
        • 7.1.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.1.3 CSL Behring Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 LFB
        • 7.2.1 LFB Human Fibrinogen Production Sites and Area Served
        • 7.2.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.2.3 LFB Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Shanghai RAAS
        • 7.3.1 Shanghai RAAS Human Fibrinogen Production Sites and Area Served
        • 7.3.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.3.3 Shanghai RAAS Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Boya
        • 7.4.1 Boya Human Fibrinogen Production Sites and Area Served
        • 7.4.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.4.3 Boya Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Hualan Biological Engineering
        • 7.5.1 Hualan Biological Engineering Human Fibrinogen Production Sites and Area Served
        • 7.5.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.5.3 Hualan Biological Engineering Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Harbin Pacific Biopharmaceutical
        • 7.6.1 Harbin Pacific Biopharmaceutical Human Fibrinogen Production Sites and Area Served
        • 7.6.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Greencross
        • 7.7.1 Greencross Human Fibrinogen Production Sites and Area Served
        • 7.7.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.7.3 Greencross Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Shanghai XinXing Medical
        • 7.8.1 Shanghai XinXing Medical Human Fibrinogen Production Sites and Area Served
        • 7.8.2 Human Fibrinogen Product Introduction, Application and Specification
        • 7.8.3 Shanghai XinXing Medical Human Fibrinogen Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served

      8 Human Fibrinogen Manufacturing Cost Analysis

      • 8.1 Human Fibrinogen Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Human Fibrinogen
      • 8.4 Human Fibrinogen Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Human Fibrinogen Distributors List
      • 9.3 Human Fibrinogen Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Human Fibrinogen Market Forecast

      • 11.1 Global Human Fibrinogen Production, Revenue Forecast
        • 11.1.1 Global Human Fibrinogen Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Human Fibrinogen Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Human Fibrinogen Price and Trend Forecast (2019-2025)
      • 11.2 Global Human Fibrinogen Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Human Fibrinogen Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Human Fibrinogen Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Human Fibrinogen Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Human Fibrinogen Production, Revenue Forecast (2019-2025)
      • 11.3 Global Human Fibrinogen Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Human Fibrinogen Consumption Forecast (2019-2025)
        • 11.3.2 Europe Human Fibrinogen Consumption Forecast (2019-2025)
        • 11.3.3 China Human Fibrinogen Consumption Forecast (2019-2025)
        • 11.3.4 Japan Human Fibrinogen Consumption Forecast (2019-2025)
      • 11.4 Global Human Fibrinogen Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Human Fibrinogen Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Fibrinogen is a protein in the blood plasma that is essential for the coagulation of blood and is converted to fibrin by the action of thrombin in the presence of ionized calcium. Human fibrinogen is a protein which is important for blood clotting (coagulation).
        The industry is concentration, the key brand include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, Greencross, Shanghai XinXing Medical and so on. Among them, CSL Behring and LFB are the leaders.

        The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.

        The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.

        Significant and lasting barriers make entry into this market difficult. These barriers include, but are not limited to: (i) product development costs; (ii) capital requirements; (iii) intellectual property rights; (iv) regulatory requirement; and (v) Transitions’ unfair methods of competition.

        Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. Even so, the market is intensely competitive .The study group recommends the new entrants just having money but without technical advantage and upstream and downstream support do not to enter into this field.

        The global Human Fibrinogen market is valued at 470 million US$ in 2018 is expected to reach 2820 million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025.
        This report focuses on Human Fibrinogen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Fibrinogen market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        CSL Behring
        LFB
        Shanghai RAAS
        Boya
        Hualan Biological Engineering
        Harbin Pacific Biopharmaceutical
        Greencross
        Shanghai XinXing Medical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Pure Human Fibrinogen
        Fibrinogen Concentrate (Human)

        Segment by Application
        Congenital Fibrinogen Deficiency
        Surgical Procedures

        Buy now